This is the module test for ‘Thrombolysis’. It is strongly recommended that you work through the learning materials of the module prior to commencing this test. By going straight to the test you may miss out on valuable learning contained within the module. The answers to all the test questions are contained within the module. This information may have been provided in the ‘Additional Information’ boxes on some of the pages.
To gain a certificate of completion you will need to answer at least 18 of the 20 questions (90%) correctly
You should allow approximately 20 minutes to complete the test.
For testing – Correct answers:
Part 1. Q. What does ‘thrombolysis’ mean?
- Retrieval of blood clots
- Breaking up of blood clots – Correct, thrombolysis means the ‘breaking up of blood clots’.
- Formation of blood clots
- Dislodging of blood clots
Part 2. Q. Thrombolysis treatment increases the chances of a fuller recovery; however is it is not effective in every case.
- True – Correct, this statement is true.
- False
Part 3. Q. What type of diagnosis should thrombolysis treatment be considered for?
- Intracerebral haemorrhage
- Subdural haematoma
- Subarchnoid haemorrhage
- Ischaemic – Correct, thrombolysis treatment should be considered for ischaemic stroke.
Part 4. Q. What is the maximum time period between onset of symptoms and giving thrombolysis treatment after a stroke event?
- 1 hour
- 4.5 hours – Correct, thrombolysis treatment should be given within 4.5 hours after the stroke event.
- 8 hours
- 24 hours
Part 5. Q. What does NIHSS stand for?
- Neurological Institutes of Health Stroke Scale
- National Instrument of Health Stroke Scale
- National Institutes of Health Stroke Scale – Correct, NIHSS stands for National Institutes of Health Stroke Scale.
- Northern Ireland Health Stroke Services
Part 6. Q. What should you advise someone to do if they come upon a person having a suspected stroke?
- Call NHS 24
- Call the G.P.
- Call 999 – Correct, you should call 999 if you suspect someone is having a stroke.
- Wait and see what happens
Part 7. Q. The FAST tool can be used to help recognise someone is having a suspected stroke?
- True – Correct, the FAST tool can be used to help recognise someone is having a suspected stroke.
- False
Part 8. Q. Which of the following is a contraindication for thrombolysis treatment?
- Type 1 Diabetes Mellitus
- Recent severe or dangerous bleeding – Correct, recent severe or dangerous bleeding is a contraindication for thrombolysis treatment.
- Smoker
- NIHSS score of 16
Part 9. Q. A history and physical examination of the patient will distinguish an ischaemic from a haemorrhagic stroke
- True
- False – Correct, a history and physical examination of the patient will not distinguish an ischaemic from a haemorrhagic stroke.
Part 10. Q. What does a ROSIER score of 3 mean?
- Stroke is unlikely
- Stroke symptoms have resolved
- Need to consider another diagnosis
- Stroke is likely – Correct, a ROSIER score of 3 means that stroke is likely.
Part 11. Q. How much of the total dose of Alteplase is administered by intravenous bolus?
- 100%
- 20%
- 10% – Correct, 10% of the total dose of Alteplase is administered by intravenous bolus.
- 2%
Part 12. Q. Which of these is NOT a stroke mimic?
- Hypertension – Correct, hypertension is NOT a stroke mimic.
- Migraine
- Hypoglycaemia
- Epileptic seizure
Part 13. Q. When assessing if someone is suitable for thrombolysis treatment which of the following should NOT be done immediately?
- NIHSS
- CT Scan
- Bedside swallow assessment – Correct, a bedside swallow assessment should NOT be done when assessing if someone is suitable for thrombolysis treatment.
- Confirm time of symptom onset
Part 14. Q. An MRI scan should always be carried out before administering thrombolysis treatment?
- True
- False – Correct, an MRI scan should NOT always be carried out before administering thrombolysis treatment.
Part 15. Q. Which of the following is NOT assessed in the NIHSS?
- Visual field loss
- Dysphagia – Correct, dysphagia is NOT assessed in the NIHSS.
- Sensory loss
- Level of consciousness
Part 16. Q. In order to get one extra patient fully recovered, how many patients do you need to treat with thrombolysis?
- 1:3
- 1:8 – Correct, you would need to treat eight patients in order to get one extra patient fully recovered.
- 1:25
- 1:100
Part 17. Q. What does NOT require to be regularly monitored following thrombolysis treatment?
- Central venous pressure – Correct, central venous pressure does NOT require to be regularly monitored following thrombolysis treatment.
- Blood pressure
- Abbreviated NIHSS
- Modified Early Warning System
Part 18. Q. Which of the following are the most common drug reactions / side effects of thrombolysis treatment?
- Sweating and pyrexia
- Angio-oedema and bleeding – Correct, angio-oedema and bleeding are the most common drug reactions / side effects of thrombolysis treatment.
- Diarrhoea and vomiting
- Cardiac arrhythmia and chest pain
Part 19. Q. SIGN Guideline 108 Grade A evidence – Patients admitted with stroke within four and a half hours of definite onset of symptoms, who are considered suitable, should be treated with intravenous thrombolysis?
- True – Correct, patients admitted with stroke within four and a half hours of definite onset of symptoms, who are considered suitable, should be treated with intravenous thrombolysis.
- False
Part 20. Q. Used appropriately thrombolysis is a safe and effective treatment following ischaemic stroke.
- True – Correct, used appropriately thrombolysis is a safe and effective treatment following ischaemic stroke.
- False
Well done, you have answered all the questions correctly. Now print off a copy of your certificate which indicates that you have successfully completed this module.
[[MR:C06A1113548]] Please note: if you do not click on either of the links below there will be no permanent record of your certificate and you will be required to sit the test again.
Unfortunately you have not answered all the questions correctly. We suggest that you revise the module and undertake the test again on another occasion.
Back to: 01: Thrombolysis module home page
Back to: Advancing Modules